FASLG and obesity disorder: FAS and FASL gene expression levels were assessed according to the presence and absence of comorbidities (Figure S1) and among individuals with different types of comorbidities (diabetes mellitus, cardiovascular disease, and obesity) and individuals without these conditions (Figure S2); however, none of the analyses showed a significant association.